148 related articles for article (PubMed ID: 9883926)
1. Anti-U and haemolytic disease of the fetus and newborn.
Smith G; Knott P; Rissik J; de la Fuente J; Win N
Br J Obstet Gynaecol; 1998 Dec; 105(12):1318-21. PubMed ID: 9883926
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of ABO haemolytic disease of the newborn.
Voak D
Vox Sang; 1969 Dec; 17(6):481-513. PubMed ID: 5373123
[No Abstract] [Full Text] [Related]
3. [Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].
Tantalo V; Rossi E; Gianotti GA; Morotti R; Zuliani G; Buscaglia M; Galligani M
Ann Ostet Ginecol Med Perinat; 1990; 111(5):321-5. PubMed ID: 2092607
[TBL] [Abstract][Full Text] [Related]
4. Anti-D concentration in mother and child in haemolytic disease of the newborn.
Hughes-Jones NC; Ivona M; Ellis J; Walker W
Vox Sang; 1971 Aug; 21(2):135-40. PubMed ID: 5000958
[No Abstract] [Full Text] [Related]
5. Management of pregnancies complicated by anti-E alloimmunization.
Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
[TBL] [Abstract][Full Text] [Related]
6. Severe ABO haemolytic disease due to high titre IgG anti-B in an A2 mother.
Graham H; Morrison M; Casey E
Vox Sang; 1974; 27(4):363-8. PubMed ID: 4213379
[No Abstract] [Full Text] [Related]
7. [An at-risk pregnancy caused by an irregular complement-activating nonspecific alloantibody in maternal serum].
Ratei R
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):731-2. PubMed ID: 3234706
[TBL] [Abstract][Full Text] [Related]
8. Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation.
Garner SF; Wiener E; Contreras M; Nicolini U; Kochenour N; Letsky E; Rodeck CH
Br J Haematol; 1992 Jan; 80(1):97-101. PubMed ID: 1536816
[TBL] [Abstract][Full Text] [Related]
9. Haemolytic disease of the newborn due to anti-Mt a .
Field TE; Wilson TE; Dawes BJ; Giles CM
Vox Sang; 1972; 22(5):432-7. PubMed ID: 5032416
[No Abstract] [Full Text] [Related]
10. Chromatographic separation and serologic analysis of antibodies in the sera of mothers with ABO incompatibility.
KuĊnierz G
Arch Immunol Ther Exp (Warsz); 1974; 22(2):161-5. PubMed ID: 4209990
[No Abstract] [Full Text] [Related]
11. Red cell antibodies in pregnancy: there is no 'critical titre'.
van Dijk BA; Dooren MC; Overbeeke MA
Transfus Med; 1995 Sep; 5(3):199-202. PubMed ID: 8593524
[TBL] [Abstract][Full Text] [Related]
12. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
13. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.
Bowell P; Wainscoat JS; Peto TE; Gunson HH
Br Med J (Clin Res Ed); 1982 Jul; 285(6338):327-9. PubMed ID: 6284295
[TBL] [Abstract][Full Text] [Related]
14. Autologous intrauterine transfusion in a case of anti-U.
Adam S; Lombaard H
Transfusion; 2016 Dec; 56(12):3029-3032. PubMed ID: 27664105
[TBL] [Abstract][Full Text] [Related]
15. The significance of anti-Kell sensitization in pregnancy.
Mayne KM; Bowell PJ; Pratt GA
Clin Lab Haematol; 1990; 12(4):379-85. PubMed ID: 2081378
[TBL] [Abstract][Full Text] [Related]
16. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
17. Management of immune haemolytic disease in the fetus.
Tannirandorn Y; Rodeck CH
Blood Rev; 1991 Mar; 5(1):1-14. PubMed ID: 2032024
[TBL] [Abstract][Full Text] [Related]
18. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
[TBL] [Abstract][Full Text] [Related]
19. Value of maternal anti-D concentration in predicting the outcome of Rh(D) haemolytic disease.
Harrison KL; Baker JW; Popper EI; Harden PA
Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):6-8. PubMed ID: 6430264
[TBL] [Abstract][Full Text] [Related]
20. Haemolytic disease of the newborn because of rare anti-Vel.
van Gammeren AJ; Overbeeke MA; Idema RN; van Beek RH; Ten Kate-Booij MJ; Ermens AA
Transfus Med; 2008 Jun; 18(3):197-8. PubMed ID: 18598283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
